Note: Ingredients listed on restricted chemical lists
EC/CAS
25322-68-3
Name of the chemical
polyethyleneglycol
Concentration
0.6-<2
EC/CAS
13463-67-7
Name of the chemical
Reaction mass of titanium dioxide and silver chloride
Concentration
3-6
EC/CAS
7631-86-9
Name of the chemical
Silver adsorbed on silicon dioxide
Concentration
>36.0
General Information
Revision date
2020-02-17
Product name
COMBIVIR TABLETS
Product Synonyms
COMBIVIR 150 MG/300 MG FILMTABLETTEN * COMBIVIR 150 MG/300 MG FILMTABLETTA *
Emergency telephone
VERISK 3E GLOBAL INCIDENT RESPONSE
Icons in SDS
Company Information
company name
ViiV Healthcare Limited
e-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
GHS Information
Signal word
Danger
Section 2
Physical hazards
Not classified.
Health hazards
Serious eye damage/eye irritation Category 2 Germ cell mutagenicity Category 2 Carcinogenicity Category 2 Reproductive toxicity Category 2 Specific target organ toxicity, repeated Category 1 exposure
Environmental hazards
Not classified. OSHA defined hazards Not classified.
Signal word
Danger
Hazard statements
Causes serious eye irritation. Suspected of causing genetic defects. Suspected of causing cancer. Suspected of damaging fertility or the unborn child. Causes damage to organs through prolonged or repeated exposure.
Prevention
Obtain special instructions before use. Do not handle until all safety precautions have been read and understood. Do not breathe dust/fume/gas/mist/vapors/spray. Wash thoroughly after handling. Do not eat, drink or smoke when using this product. Wear protective gloves/protective clothing/eye protection/face protection.
Response
If in eyes: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. If exposed or concerned: Get medical advice/attention. If eye irritation persists: Get medical advice/attention.
Storage
Store locked up.
Disposal
Dispose of contents/container in accordance with local/regional/national/international regulations. Hazard(s) not otherwise Caution - Pharmaceutical agent. See section 11 of the SDS for additional information on health
Classified (HNOC)
hazards.
Additional information
42.04% of the mixture consists of component(s) of unknown acute oral toxicity. 100% of the mixture consists of component(s) of unknown acute hazards to the aquatic environment. 84.44% of the mixture consists of component(s) of unknown long-term hazards to the aquatic environment.
